| 000 | 01374 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512023920.0 | ||
| 264 | 0 | _c19880728 | |
| 008 | 198807s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1988.tb31824.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarbaugh, R E | |
| 245 | 0 | 0 |
_aIntracerebroventricular bethanechol chloride administration in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _c1988 |
||
| 300 |
_a174-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aBethanechol |
| 650 | 0 | 4 |
_aBethanechol Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aEquipment Failure |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfusion Pumps _xadverse effects |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMental Status Schedule |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 531 _gp. 174-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1988.tb31824.x _zAvailable from publisher's website |
| 999 |
_c2904074 _d2904074 |
||